Results 21 to 30 of about 9,772 (228)

Association between response to triptans and response to erenumab: real-life data

The Journal of Headache and Pain, 2021
Background Triptans and erenumab are both migraine-specific agents acting on the calcitonin gene-related peptide pathway. Therefore, response to triptans might be associated with response to erenumab.
Ilaria Frattale, Valeria Caponnetto, Alfonsina Casalena, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Giannapia Affaitati, Maria Adele Giamberardino, Stefano Viola, Amleto Gabriele, Francesca Pistoia, Davide Cerone, Carmine Marini, Simona Sacco, Raffaele Ornello   +14 more
doaj   +1 more source

The relationship between patients’ income and education and their access to pharmacological chronic pain management: A scoping review

Canadian Journal of Pain, 2022
Background Though chronic pain is widespread, affecting about one-fifth of the world’s population, its impacts are disproportionately felt across the population according to socioeconomic determinants such as education and income.
Nicole Atkins, Karim Mukhida
doaj   +1 more source

Cardiovascular safety of triptans in the acute treatment of migraine

Медицинский совет, 2014
The article highlights the issues of safety when using triptans in the treatment of migraine and the risks of cardiovascular complications. Results of a large prospective population study are provided demonstrating that triptans in patients with migraine
G. R. Tabeyeva
doaj   +1 more source

P003. NSAIDs for symptomatic treatment of headache [PDF]

, 2015
Background and aims Clinical observations suggest that the use of non-steroidal anti-inflammatory drugs (NSAIDs) for symptomatic treatment of headache is not in line with recommendations by international guidelines [1].
Affaitati, Giannapia, Cipollone, Francesco, Costantini, Raffaele, Giamberardino, Maria Adele, Lapenna, Domenico, Lopopolo, Mariangela, Martelletti, Paolo, Massimini, Francesca, Tana, Claudio   +8 more
core   +1 more source

Fremanezumab for the Preventive Treatment of Chronic Migraine. [PDF]

, 2017
BACKGROUND: Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investigated as a preventive treatment for migraine.
Aycardi, Ernesto, Bigal, Marcelo E., Blankenbiller, Tricia, Dodick, David W., Goadsby, Peter J., Grozinski-Wolff, Melissa, Ma, Yuju, Silberstein, Stephen D., Yang, Ronghua, Yeung, Paul P.   +9 more
core   +2 more sources

Novel pharmaceutical dosage forms of analgesics [PDF]

Arhiv za farmaciju, 2018
Among novel pharmaceutical dosage forms of analgesics, whose number and diversity are continuously increasing over the past two decades, of particular importance are transdermal opioid analgesics (fentanyl, buprenorphine) for the treatment of chronic ...
Đekić Ljiljana, Primorac Marija
doaj   +1 more source

The effect of placebo and neurophysiological involvements [PDF]

, 2004
Placebo and placebo effect are important issues related to the drug therapy for clinical and scientific meanings. The rates of placebo may get as many as 50% for analgesic drugs in headache. The high answer to placebo brings questions on pathophysiology
Galli, Federica, Guidetti, Vincenzo, Riccio, B.   +2 more
core   +1 more source

Triptans in treatment of migraine

Медицинский совет, 2015
Migraine is one of the most common neurological disease that manifests itself in severe headache attacks. It is one of the most widespread causes of disability in young and middle-aged people.
V. A. Golovacheva, V. A. Parfyonov
doaj   +1 more source

Current therapies in episodic migraine management [PDF]

Romanian Journal of Neurology, 2014
Migraine is a common neurological disease characterized by severe, recurrent episodes of throbbing, unilateral, headache. Non pharmacologic migraine treatment refers to the patient behavioural modification in order to avoid trigger.
Adina Roceanu, Ovidiu Bajenaru
doaj   +1 more source

Noninvasive vagus nerve stimulation as acute therapy for migraine. The randomized PRESTO study [PDF]

, 2018
Objective: To evaluate the efficacy, safety, and tolerability of noninvasive vagus nerve stimulation (nVNS; gammaCore; electroCore, LLC, Basking Ridge, NJ) for the acute treatment of migraine in a multicenter, double-blind, randomized, sham-controlled ...
Ambrosini, Anna, Barbanti, Piero, De Tommaso, Marina, Dorlas, Stefanie, Geppetti, Pierangelo, Grazzi, Licia, Liebler, Eric, Martelletti, Paolo, Negro, Andrea, Pierangeli, Giulia, Rainero, Innocenzo, Sarchielli, Paola, Tassorelli, Cristina   +12 more
core   +2 more sources